Keyphrases
MRNA Vaccine
100%
SARS-CoV-2 Omicron
100%
Omicron Strain
100%
Wuhan
75%
MRNA-1273
75%
BA.1
75%
Tumor-draining Lymph Nodes
50%
Lung
25%
Antigen-specific
25%
Neutralizing Antibodies
25%
B Cells
25%
T Cells
25%
K18-hACE2 Mice
25%
Two-dose
25%
CD8+ T Cells
25%
Monovalent Cations
25%
Germinal Center B Cells
25%
Spleen
25%
IgG Antibody
25%
Plasma Cells
25%
Pregenomic RNA (pgRNA)
25%
RNA Virus
25%
COVID-19
25%
T Cell Immune Response
25%
Infectious Virus
25%
Virus Challenge
25%
Immune Protection
25%
Viral Infectious
25%
Plasmablast
25%
T Follicular Helper Cells
25%
Equivalent Reduction
25%
Spike Protein
25%
Emerging SARS-CoV-2 Variants
25%
Third mRNA Vaccine Dose
25%
Serum Neutralizing Antibodies
25%
Nasal Turbinate
25%
B-cell Immune Response
25%
Priming Dose
25%
Impact Protection
25%
IgG Antibody Response
25%
Medicine and Dentistry
Contralateral
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
mRNA Vaccine
100%
Omicron Coronavirus Variant
100%
Messenger RNA
62%
B Cell
37%
Lymph Node
25%
T Cell
25%
Virus RNA
25%
Antigen Specificity
12%
Arm
12%
Immune Response
12%
Cytotoxic T-Cell
12%
Germinal Center
12%
Antibody Response
12%
Immunity
12%
Neutralizing Antibody
12%
Virus Infectivity
12%
K 18
12%
Turbinate
12%
T Follicular Helper Cell
12%
Plasmablast
12%
Lung
12%
Immunoglobulin Producing Cell
12%
Virus
12%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
mRNA Vaccine
100%
Messenger RNA
100%
Virus RNA
40%
Neutralizing Antibody
20%
CD8 Antigen
20%
Virus Infectivity
20%
K 18
20%